What is the Optimum Screening Strategy for the Early Detection of Lung Cancer

Clinical Oncology

Volumn 28, Issue 11, 2016, Pages 672-681

  Baldwin, D R ^a   Callister, M E J ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Computed tomography screening; implementation; lung cancer; nodules

Indexed keywords

ANXIETY; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISTRESS SYNDROME; EARLY CANCER DIAGNOSIS; FALSE POSITIVE RESULT; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; IMAGE RECONSTRUCTION; INCIDENTAL FINDING; LIFE EXPECTANCY; LUNG CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIATION DOSE; RADIATION EXPOSURE; RADIATION SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SURVIVAL TIME; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TUMOR VOLUME; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; ECONOMICS; LUNG NEOPLASMS; PROCEDURES; STANDARDS; X-RAY COMPUTED TOMOGRAPHY;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84991662066     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2016.08.001     Document Type: Article

References (94)

1. [1] Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
2. [2] Coleman, M.P., Forman, D., Bryant, H., et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377 (2011), 127–138.
3. [3] De Angelis, R., Sant, M., Coleman, M.P., et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol 15 (2014), 23–34.
4. [4] Saghir, Z., Dirksen, A., Ashraf, H., et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 67 (2012), 296–301.
5. [5] Veronesi, G., Maisonneuve, P., Spaggiari, L., et al. Diagnostic performance of low-dose computed tomography screening for lung cancer over five years. J Thorac Oncol 9 (2014), 935–939.
6. [6] National Lung Screening Trial Research, Aberle, D.R., Adams, A.M., Berg, C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med 365 (2011), 395–409.
7. [7] National Lung Screening Trial Research, Aberle, D.R., Berg, C.D., Black, W.C., et al. The National Lung Screening Trial: overview and study design. Radiology 258 (2011), 243–253.
8. [8] Kovalchik, S.A., Tammemagi, M., Berg, C.D., et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 369 (2013), 245–254.
9. [9] Tammemagi, M.C., Church, T.R., Hocking, W.G., et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med, 11, 2014, e1001764.
10. [10] van Iersel, C.A., de Koning, H.J., Draisma, G., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120 (2007), 868–874.
11. [11] Xu, D.M., Gietema, H., de Koning, H., et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 54 (2006), 177–184.
12. [12] van Klaveren, R.J., Oudkerk, M., Prokop, M., et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 361 (2009), 2221–2229.
13. [13] Baldwin, D.R., Duffy, S.W., Wald, N.J., Page, R., Hansell, D.M., Field, J.K., UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66 (2011), 308–313.
14. [14] Field, J.K., Duffy, S.W., Baldwin, D.R., et al. UK lung cancer RCT pilot screening trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170.
15. [15] Pastorino, U., Rossi, M., Rosato, V., et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prevent 21 (2012), 308–315.
16. [16] Infante, M., Cavuto, S., Lutman, F.R., et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 180 (2009), 445–453.
17. [17] Infante, M., Cavuto, S., Lutman, F.R., et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 191 (2015), 1166–1175.
18. [18] Wille, M.M., Dirksen, A., Ashraf, H., et al. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med 193:5 (2016), 542–551.
19. [19] Becker, N., Motsch, E., Gross, M.L., et al. Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization. J Thorac Oncol 10 (2015), 890–896.
20. [20] Lopes Pegna, A., Picozzi, G., Mascalchi, M., et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64 (2009), 34–40.
21. [21] Blanchon, T., Brechot, J.M., Grenier, P.A., et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58 (2007), 50–58.
22. [22] Field, J.K., Hansell, D.M., Duffy, S.W., Baldwin, D.R., CT screening for lung cancer: countdown to implementation. Lancet Oncol 14 (2013), e591–e600.
23. [23] Humphrey, L.L., Deffebach, M., Pappas, M., et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US preventive services task force recommendation. Ann Intern Med 159 (2013), 411–420.
24. [24] Verma, V., Beriwal, S., Medicare approves coverage for lung cancer screening: the case for symptomatic screening. JAMA Oncol 1:8 (2015), 1027–1028.
25. [25] Field, J.K., Smith, R.A., Aberle, D.R., et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thoracic Oncol 7 (2012), 10–19.
26. [26] Black, W.C., Gareen, I.F., Soneji, S.S., et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371 (2014), 1793–1802.
27. [27] Wilson, D.O., Weissfeld, J., A simple model for predicting lung cancer occurrence in a lung cancer screening program: the Pittsburgh Predictor. Lung Cancer 89 (2015), 31–37.
28. [28] Tammemagi, M.C., Application of risk prediction models to lung cancer screening: a review. J Thorac Imaging 30 (2015), 88–100.
29. [29] Howard, D.H., Richards, T.B., Bach, P.B., et al. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer 121:24 (2015), 4341–4347.
30. [30] Ionising radiation: dose comparisons. Available at: https://www.gov.uk/government/publications/ionising-radiation-dose-comparisons/ionising-radiation-dose-comparisons.
31. [31] de Koning, H.J., Meza, R., Plevritis, S.K., et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160 (2014), 311–320.
32. [32] Sinsuat, M., Saita, S., Kawata, Y., et al. Influence of slice thickness on diagnoses of pulmonary nodules using low-dose CT: potential dependence of detection and diagnostic agreement on features and location of nodule. Academic Radiol 18 (2011), 594–604.
33. [33] Lee, H.Y., Goo, J.M., Lee, H.J., et al. Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules. Clin Radiol 64 (2009), 127–132.
34. [34] Fischbach, F., Knollmann, F., Griesshaber, V., Freund, T., Akkol, E., Felix, R., Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 13 (2003), 2378–2383.
35. [35] Cui, Y., Ma, D.-Q., Liu, W.-H., Value of multiplanar reconstruction in MSCT in demonstrating the relationship between solitary pulmonary nodule and bronchus. Clin Imaging 33 (2009), 15–21.
36. [36] Jankowski, A., Martinelli, T., Timsit, J.F., et al. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol 17 (2007), 3148–3156.
37. [37] Kawel, N., Seifert, B., Luetolf, M., Boehm, T., Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. Am J Roentgenol 192 (2009), 1324–1329.
38. [38] Matsumoto, S., Ohno, Y., Yamagata, H., Nogami, M., Kono, A., Sugimura, K., Potential contribution of multiplanar reconstruction (MPR) to computer-aided detection of lung nodules on MDCT. Eur J Radiol 81 (2012), 366–370.
39. [39] Valencia, R., Denecke, T., Lehmkuhl, L., Fischbach, F., Felix, R., Knollmann, F., Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol 16 (2006), 325–332.
40. [40] Revel, M.P., Bissery, A., Bienvenu, M., Aycard, L., Lefort, C., Frija, G., Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?. Radiology 231:2 (2004), 453–458.
41. [41] Korst, R.J., Lee, B.E., Krinsky, G.A., Rutledge, J.R., The utility of automated volumetric growth analysis in a dedicated pulmonary nodule clinic. J Thoracic Cardiovasc Surg 142 (2011), 372–377.
42. [42] Horeweg, N., van der Aalst, C.M., Vliegenthart, R., et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 42 (2013), 1659–1667.
43. [43] Xu, D.M., van der Zaag-Loonen, H.J., Oudkerk, M., et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 250 (2009), 264–272.
44. [44] Nair, A., Gartland, N., Barton, B., et al. Comparing the performance of trained radiographers against experienced radiologists in the UK Lung Cancer Screening (UKLS) Trial. Brit J Radiol, 2016 in press.
45. [45] Pauli, R., Hammond, S., Cooke, J., Ansell, J., Radiographers as film readers in screening mammography: an assessment of competence under test and screening conditions. Br J Radiol 69 (1996), 10–14.
46. [46] Roos, J.E., Paik, D., Olsen, D., et al. Computer-aided detection (CAD) of lung nodules in CT scans: radiologist performance and reading time with incremental CAD assistance. Eur Radiol 20 (2010), 549–557.
47. [47] Armato, I.S.G., Roy, A.S., MacMahon, H., et al. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program. Acad Radiol 12:3 (2005), 337–346.
48. [48] Godoy, M.C.B., Cooperberg, P.L., Maizlin, Z.V., et al. Detection sensitivity of a commercial lung nodule CAD system in a series of pathologically proven lung cancers. J Thoracic Imag 23:1 (2008), 1–6.
49. [49] Zhao, Y., de Bock, G.H., Vliegenthart, R., et al. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 22 (2012), 2076–2084.
50. [50] Horeweg, N., Rosmalen, J., Heuvelmans, M.A., et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15 (2014), 1332–1341.
51. [51] Callister, M.E., Baldwin, D.R., Akram, A.R., et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70:Suppl. 2 (2015), ii1–ii54.
52. [52] McWilliams, A., Tammemagi, M.C., Mayo, J.R., et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369 (2013), 910–919.
53. [53] Al-Ameri, A., Malhotra, P., Thygesen, H., et al. Risk of malignancy in pulmonary nodules: a validation study of four prediction models. Lung Cancer 89 (2015), 27–30.
54. [54] Herder, G.J., van Tinteren, H., Golding, R.P., et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 128 (2005), 2490–2496.
55. [55] Horeweg, N., Scholten, E.T., de Jong, P.A., et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 15 (2014), 1342–1350.
56. [56] Field, J.K., Duffy, S.W., Baldwin, D.R., et al. UK lung cancer RCT pilot screening trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71:2 (2016), 161–170.
57. [57] Kim, H., Park, C.M., Woo, S., et al. Pure and part-solid pulmonary ground-glass nodules: measurement variability of volume and mass in nodules with a solid portion less than or equal to 5 mm. Radiology 269 (2013), 585–593.
58. [58] Scholten, E.T., Jacobs, C., van Ginneken, B., et al. Detection and quantification of the solid component in pulmonary subsolid nodules by semiautomatic segmentation. Eur Radiol 25 (2015), 488–496.
59. [59] Henschke, C.I., Yip, R., Yankelevitz, D.F., Smith, J.P., International Early Lung Cancer Action Program I: Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 158 (2013), 246–252.
60. [60] Patz, E.F. Jr., Greco, E., Gatsonis, C., et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 17:5 (2016), 590–599.
61. [61] Yip, R., Henschke, C.I., Yankelevitz, D.F., Boffetta, P., Smith, J.P., International Early Lung Cancer I: The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. Eur J Cancer Prev 24 (2015), 201–208.
62. [62] National Lung Screening Trial Research, Church, T.R., Black, W.C., Aberle, D.R., et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 368 (2013), 1980–1991.
63. [63] Ginsberg, R.J., Rubinstein, L.V., Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60 (1995), 615–622 discussion 622–613.
64. [64] Schuchert, M.J., Abbas, G., Awais, O., et al. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg 93 (2012), 1780–1785 discussion 1786–1787.
65. [65] Verstegen, N.E., Oosterhuis, J.W., Palma, D.A., et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24 (2013), 1543–1548.
66. [66] Jacobs, P.C., Prokop, M., van der Graaf, Y., et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 209 (2010), 455–462.
67. [67] Kucharczyk, M.J., Menezes, R.J., McGregor, A., Paul, N.S., Roberts, H.C., Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J 62 (2011), 141–145.
68. [68] van de Wiel, J.C., Wang, Y., Xu, D.M., et al. Negligible benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 17 (2007), 1474–1482.
69. [69] Jacobs, P.C., Gondrie, M.J., van der Graaf, Y., et al. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. Am J Roentgenol 198 (2012), 505–511.
70. [70] Kim, Y.K., Sung, Y.M., Cho, S.H., Park, Y.N., Choi, H.Y., Reliability analysis of visual ranking of coronary artery calcification on low-dose CT of the thorax for lung cancer screening: comparison with ECG-gated calcium scoring CT. Int J Cardiovasc Imaging 30:Suppl. 2 (2014), 81–87.
71. [71] Takx, R.A., Isgum, I., Willemink, M.J., et al. Quantification of coronary artery calcium in nongated CT to predict cardiovascular events in male lung cancer screening participants: results of the NELSON study. J Cardiovasc Comput Tomogr 9 (2015), 50–57.
72. [72] Patz, E.F. Jr., Pinsky, P., Gatsonis, C., et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174 (2014), 269–274.
73. [73] van den Bergh, K.A., Essink-Bot, M.L., Borsboom, G.J., Scholten, E.T., van Klaveren, R.J., de Koning, H.J., Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 38 (2011), 154–161.
74. [74] Rasmussen, J.F., Siersma, V., Pedersen, J.H., Brodersen, J., Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 87 (2015), 65–72.
75. [75] Damiani, G., Federico, B., Basso, D., et al. Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study. BMC Public Health, 12, 2012, 99.
76. [76] Shankleman, J., Massat, N.J., Khagram, L., et al. Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer 111 (2014), 1440–1447.
77. [77] McRonald, F.E., Yadegarfar, G., Baldwin, D.R., et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res 7 (2014), 362–371.
78. [78] Quaife, S.L., Ruparel, M., Beeken, R.J., et al. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients. BMC Cancer, 16, 2016, 281.
79. [79] Camilloni, L., Ferroni, E., Cendales, B.J., et al. Methods to increase participation Working G: Methods to increase participation in organised screening programs: a systematic review. BMC Public Health, 13, 2013, 464.
80. [80] Maheswaran, R., Pearson, T., Jordan, H., Black, D., Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. J Epidemiol Community Health 60 (2006), 208–212.
81. [81] Black, W.C., Keeler, E.B., Soneji, S.S., Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med, 372, 2015, 388.
82. [82] Tanner, N.T., Kanodra, N.M., Gebregziabher, M., et al. The association between smoking abstinence and mortality in the National Lung Screening Trial. Am J Respir Crit Care Med 193 (2016), 534–541.
83. [83] Villanti, A.C., Jiang, Y., Abrams, D.B., Pyenson, B.S., A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One, 8, 2013, e71379.
84. [84] McMahon, P.M., Kong, C.Y., Bouzan, C., et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thoracic Oncol 6 (2011), 1841–1848.
85. [85] Pharoah, P.D., Sewell, B., Fitzsimmons, D., Bennett, H.S., Pashayan, N., Cost effectiveness of the NHS breast screening programme: life table model. Br Med J, 346, 2013, f2618.
86. [86] Canadian Task Force on Preventive Health, Recommendations on screening for lung cancer. CMAJ 188 (2016), 425–432.
87. [87] Kazerooni, E.A., Armstrong, M.R., Amorosa, J.K., et al. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol 13 (2016), R30–R34.
88. [88] Vertinsky, T., Forster, B., Prevalence of eye strain among radiologists: influence of viewing variables on symptoms. Am J Roentgenol 184 (2005), 681–686.
89. [89] Bach, P.B., Kattan, M.W., Thornquist, M.D., et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 95:6 (2003), 470–478.
90. [90] Spitz, M.R., Hong, W.K., Amos, C.I., et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 99:9 (2007), 715–726.
91. [91] Cassidy, A., Duffy, S.W., Myles, J.P., et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer 120:1 (2007), 1–6.
92. [92] Tammemagi, M.C., Katki, H.A., Hocking, W.G., et al. Selection criteria for lung-cancer screening. N Engl J Med 368:8 (2013), 728–736.
93. [93] Hoggart, C., Brennan, P., Tjonneland, A., et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila) 5:6 (2012), 834–846.
94. [94] Wilson, D.O., Weissfeld, J., A simple model for predicting lung cancer occurrence in a lung cancer screening program: the Pittsburgh Predictor. Lung Cancer 89:1 (2015), 31–37.